SCHEMBL19879375

SCHEMBL19879375

CC(=O)OC(CC(OC(C)=O)C(C)C)CC(OC(C)=O)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
TBXA2R P21731 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
GALR3 O60755 1/20 0.38
MAPT P10636 1/20 0.38
BLM P54132 1/20 0.38
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
HRH1 P35367 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
PGD P52209 2/20 0.33
PRKCA P17252 2/20 0.32
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15984383 0.92 TDP1 (0.40) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL12958786 0.86 TSHR (0.48) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL19879374 0.82 TSHR (0.44) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL19879376 0.81 TDP1 (0.38) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL756656 0.78 TSHR (0.50) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL1698005 0.76 TSHR (0.48) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL1232896 0.76 TSHR (0.48) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL17358635 0.74 TSHR (0.50) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL25304459 0.74 TDP1 (0.47) TSHRTDP1TRPV1CHRM2CHRM4
SCHEMBL28084580 0.73 TRPV1 (0.44) TSHRTDP1TRPV1CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9895384-B1 Abuse deterrent opioid agonist transdermal compositions and methods for their use INTEGURX THERAPEUTICS, LLC (US) 2018-02-20 US disclosed